Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors
Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors
Recruiting · NCT05055908 · Registry updated 2024-08-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2024-08-02 | NCT05055908 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hunan Province Tumor Hospital | 27 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hunan Cancer Hospital | Changsha | China | 123 |